The Landscape of Clinical Trials in Nephrology: A Systematic Review of ClinicalTrials.gov
- 1 May 2014
- journal article
- review article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 63 (5), 771-780
- https://doi.org/10.1053/j.ajkd.2013.10.043
Abstract
No abstract availableKeywords
Funding Information
- FDA (U19FD003800)
- FDA (U19FD003800)
- American Heart Association (12CRP11680033)
This publication has 19 references indexed in Scilit:
- Evolving importance of kidney disease: from subspecialty to global health burdenThe Lancet, 2013
- US Renal Data System 2012 Annual Data ReportAmerican Journal of Kidney Diseases, 2013
- Loss to Analysis in Randomized Controlled Trials in CKDAmerican Journal of Kidney Diseases, 2011
- Trial Quality in Nephrology: How Are We Measuring Up?American Journal of Kidney Diseases, 2011
- Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysisThe Lancet, 2010
- Negative trials in nephrology: what can we learn?Kidney International, 2008
- Prevalence of chronic kidney disease in population-based studies: Systematic reviewBMC Public Health, 2008
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- The Number, Quality, and Coverage of Randomized Controlled Trials in NephrologyJournal of the American Society of Nephrology, 2004
- Clinical Trial in Nephrology at Hard End Point?Journal of the American Society of Nephrology, 2004